Clinical relative biological effectiveness of carbon-ion versus photon radiotherapy derived from tumor control probability models in locally advanced non-small cell lung cancer

作者
Yong‐Long Liu,Ning-Yi Ma,Ya-Qi Li,Xing-Wen Fan,Jian Chen,Jing Mi,Zi-Zhou Mao,Meng-Yao Lu,Jun-Chao Chen,Ying Guo,Xiaoli Liu,Jingfang Mao,Guo-Liang Jiang,Kailiang Wu
出处
期刊:Cancer treatment and research communications [Elsevier BV]
卷期号:48: 101357-101357
标识
DOI:10.1016/j.ctarc.2026.101357
摘要

Background This study aimed to estimate the clinical relative biological effectiveness (cRBE) of carbon-ion radiotherapy (CIRT) versus photon radiotherapy (PRT) in patients with locally advanced non-small cell lung cancer (LA-NSCLC) receiving combined radiotherapy and systemic therapy. cRBE was calculated using the equivalent uniform dose (EUD) corresponding to 50% tumor control (D₅₀), derived from tumor control probability (TCP) modeling with 3-year locoregional control (LRC) as the primary endpoint. Methods Patients treated between 2016 and 2023 were identified. Propensity score matching was applied to balance CIRT and PRT cohorts. LRC was estimated by the Kaplan-Meier method and Cox regression. Gross tumour volume dose-volume histograms were converted to biologically effective dose (BED) and EUD. Logistic TCP models were fitted by maximum likelihood estimation. cRBE was estimated as the ratio of the D 50 physical doses for PRT and CIRT. Results A total of 244 patients were included. The CIRT group demonstrated significantly improved LRC compared with the PRT group ( p = 0.033). The best-fitted TCP parameters for 3-year LRC were D₅₀ = 15.44 Gy, k = 2.52, n = 1.00 for CIRT, and D₅₀ = 59.94 Gy, k = 4.65, n = 1.00 for PRT. The estimated cRBE for locoregional control was 3.88. Conclusion CIRT was associated with improved locoregional tumor control compared with PRT in patients with LA-NSCLC. In addition, to our knowledge, this study is the first to provide a preliminary, model-dependent estimate of the clinical RBE for tumor control in LA-NSCLC using TCP modeling with 3-year LRC as the endpoint.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
YD完成签到 ,获得积分10
1秒前
1秒前
无花果的应助被爱睡觉的鱼采纳,获得10
1秒前
DQ8733完成签到,获得积分10
2秒前
鱼曰完成签到,获得积分10
2秒前
贾文浩发布了新的文献求助10
2秒前
可爱的函函的应助被羫孔采纳,获得10
3秒前
小样QQ星完成签到,获得积分10
3秒前
BINGO发布了新的文献求助30
3秒前
4秒前
yu完成签到,获得积分10
4秒前
不想起名字完成签到,获得积分10
4秒前
CodeCraft的应助被ygj采纳,获得10
4秒前
hua完成签到,获得积分10
5秒前
林林完成签到,获得积分10
5秒前
风吹麦浪发布了新的文献求助10
5秒前
5秒前
6秒前
林森发布了新的文献求助10
6秒前
排骨炖豆角完成签到,获得积分10
7秒前
ninini完成签到 ,获得积分10
7秒前
就是梦而已完成签到,获得积分10
7秒前
思源的应助被momo采纳,获得10
8秒前
科研通AI6.4的应助被www采纳,获得10
8秒前
TINASO完成签到,获得积分10
9秒前
风吹麦浪发布了新的文献求助10
9秒前
情怀的应助被LMH采纳,获得10
11秒前
脑洞疼的应助被Eliakim采纳,获得10
11秒前
甜甜的悲发布了新的文献求助10
11秒前
12秒前
aqqq发布了新的文献求助10
12秒前
辣姜完成签到,获得积分10
13秒前
orixero的应助被369ninja采纳,获得10
13秒前
梦初完成签到,获得积分10
13秒前
lyf完成签到,获得积分10
14秒前
14秒前
fantasy的应助被七月流火采纳,获得10
14秒前
15秒前
15秒前
17秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8168144
求助须知:如何正确求助?哪些是违规求助? 9561199
关于积分的说明 21759542
捐赠科研通 7759434
什么是DOI,文献DOI怎么找? 3429948
关于科研通互助平台的介绍 2553742
邀请新用户注册赠送积分活动 2474463